Rodrigo Mora-Rodriguez conducted his Ph.D. studies in the field of Programmed Cell Death in Cancer at the German Cancer Research Center (DKFZ, Heidelberg), and his first postdoctoral training in Systems Biology at the Bioquant Center at the University of Heidelberg. Currently, Rodrigo holds the position of Associate Professor within the Faculty of Microbiology, and the Master's Program in Bioinformatics and Systems Biology at the University of Costa Rica. Over the past years, Rodrigo has successfully established his own research group, the Systems Biology of Personalized Therapy, and have been responsible for supervising several Ph.D. student, Master's students, and undergraduate students both in biological and computational fields. His research interests include the Systems Biology of miRNA regulation of tumor biology, viral infection, and sphingolipid metabolism. They have developed molecular sensors for the study of ZIKV and DENV in living cells with single-cell resolution, the role of autophagy in chemotherapy response and they have modeled the sphingolipid metabolic pathway with fluorescent sphingolipid analogues to overcome drug resistance. In addition, they have worked on several applied projects on the Human Papiloma virus and the development of a novel test to detect bladder cancer in urine. Rodrigo has mentored 1 postdoc, 3 Ph.D. students, and more than 12 Master Students (past and current).
Current role
Scientific Advisor And Co-founder at Transformative
Managing Partner & Senior Scientific Advisor at Brookline Capital Markets
Chair of the Scientific Advisory Board at Therini Bio, Inc.
Scientific Advisor at zPREDICTA
Co-Founder and Scientific Advisor at Amorphology, Inc
Access the worlds's biggest network of public org charts
Learn more